Blocking NMDA receptor signaling does not decrease hormonal counterregulation to hypoglycemia in humans

Psychoneuroendocrinology

Volumn 33, Issue 8, 2008, Pages 1069-1076

  Pais, Isabel ^a   Hubold, Christian ^a   Hallschmid, Manfred ^a   Letterer, Sebastian ^a   Oltmanns, Kerstin ^a   Schultes, Bernd ^a,b   Born, Jan ^a   Peters, Achim ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Interdisciplinary Obesity Centre   (Switzerland)

Author keywords

Glutamate signaling; Hypoglycemia; Hypoglycemia counterregulation; NMDA receptor

Indexed keywords

ADRENALIN; CATECHOLAMINE; CORTICOTROPIN; GLUCAGON; GLUTAMIC ACID; GROWTH HORMONE; HYDROCORTISONE; INSULIN; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN; PLACEBO;

ADRENALIN RELEASE; ADULT; ANXIETY; ARTICLE; BLURRED VISION; BOLUS INJECTION; CONCENTRATION LOSS; CORTICOTROPIN RELEASE; COUNTERREGULATION; DIZZINESS; FAINTNESS; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEART PALPITATION; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HUNGER; HYDROCORTISONE RELEASE; HYPOGLYCEMIA; IRRITABILITY; MALE; MOOD; NEUROGLYCOPENIC SYMPTOM; NORADRENALIN RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN TINGLING; STATISTICAL ANALYSIS; SWEATING; SYMPTOM; TREMOR; VOLUNTEER;

ADRENOCORTICOTROPIC HORMONE; ADULT; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEEDBACK, BIOCHEMICAL; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; INSULIN; MALE; MEMANTINE; PLACEBOS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 49049111068     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.04.002     Document Type: Article

References (38)

1. Adams H.A., Thiel A., Jung A., Fengler G., and Hempelmann G. Studies using S-(+)-ketamine on probands. Endocrine and circulatory reactions, recovery and dream experiences. Anaesthesist 41 10 (1992) 588-596
2. Amiel S.A. Counterregulation to hypoglycaemia: physiology. Ann. Endocrinol. (Paris) 65 1 (2004) 85-87
3. Bertrand G., Gross R., Puech R., Loubatières-Mariani M.M., and Bockaert J. Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. Eur. J. Pharmacol. 237 1 (1993) 45-50
4. Bradbury M.J., Giracello D.R., Chapman D.F., Holtz G., Schaffhauser H., Rao S.P., Varney M.A., and Anderson J.J. Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic-pituitary-adrenal axis activity: interaction with serotonergic systems. Neuropharmacology 44 5 (2003) 562-572
5. Brann D.W. Glutamate: a major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology 61 3 (1995) 213-225
6. Broadbear J.H., Winger G., and Woods J.H. Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology (Berl) 176 3/4 (2004) 398-406
7. Cox D.J., Gonder-Frederick L., Antoun B., Cryer P.E., and Clarke W.L. Perceived symptoms in the recognition of hypoglycemia. Diabetes Care 16 2 (1993) 519-527
8. Darlington D.N., Miyamoto M., Keil L.C., and Dallman M.F. Paraventricular stimulation with glutamate elicits bradycardia and pituitary responses. Am. J. Physiol. 256 1 Pt 2 (1989) R112-R119
9. Deary I.J., Hepburn D.A., MacLeod K.M., and Frier B.M. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 36 8 (1993) 771-777
10. Dinse H.R., Ragert P., Pleger B., Schwenkreis P., and Tegenthoff M. Pharmacological modulation of perceptual learning and associated cortical reorganization. Science 301 5629 (2003) 91-94
11. Elvidge H., Challis J.R., Robinson J.S., Roper C., and Thorburn G.D. Influence of handling and sedation on plasma cortisol in rhesus monkeys (Macaca mulatta). J. Endocrinol. 70 2 (1976) 325-326
12. Farah Jr. J.M., Rao T.S., Mick S.J., Coyne K.E., and Iyengar S. N-Methyl-d-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat. Endocrinology 128 4 (1991) 1875-1880
13. Gay V.L., and Plant T.M. N-Methyl-d,l-aspartate elicits hypothalamic gonadotropin-releasing hormone release in prepubertal male rhesus monkeys (Macaca mulatta). Endocrinology 120 6 (1987) 2289-2296
14. Gerich J.E., Mokan M., Veneman T., Korytkowski M., and Mitrakou A. Hypoglycemia unawareness. Endocr. Rev. 12 4 (1991) 356-371
15. Iyengar S., Mick S., Dilworth V., Michel J., Rao T.S., Farah J.M., and Wood P.L. Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology 29 3 (1990) 299-303
16. Jezova D., Tokarev D., and Rusnak M. Endogenous excitatory amino acids are involved in stress-induced adrenocorticotropin and catecholamine release. Neuroendocrinology 62 4 (1995) 326-332
17. Kim D.H., Moon Y.S., Jung J.S., Suh H.W., and Song D.K. Route-dependent effects of the non-NMDA receptor antagonist CNQX on plasma corticosterone levels in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 6 (2003) 1055-1058
18. Kornhuber J., and Quack G. Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man. Neurosci. Lett. 195 2 (1995) 137-139
19. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers Jr. M.B., and Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51 3 (1994) 199-214
20. Lipton S.A. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr. Alzheimer Res. 2 2 (2005) 155-165
21. Meeker R.B., Greenwood R.S., and Hayward J.N. Glutamate receptors in the rat hypothalamus and pituitary. Endocrinology 134 2 (1994) 621-629
22. Molina P.E., and Abumrad N.N. Contribution of excitatory amino acids to hypoglycemic counter-regulation. Brain Res. 899 1/2 (2001) 201-208
23. Nakanishi S. Molecular diversity of the glutamate receptors. Clin. Neuropharmacol. 15 Suppl. 1 Pt A (1992) 4A-5A
24. Parsons C.G., Stoffler A., and Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 53 6 (2007) 699-723
25. Peters A., Schweiger U., Pellerin L., Hubold C., Oltmanns K.M., Conrad M., Schultes B., Born J., and Fehm H.L. The selfish brain: competition for energy resources. Neurosci. Biobehav. Rev. 28 2 (2004) 143-180
26. Porter R.H., and Greenamyre J.T. Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J. Neurochem. 64 2 (1995) 614-623
27. Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., and Mobius H.J. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J Med. 348 14 (2003) 1333-1341
28. Reyes A., Luckhaus J., and Ferin M. Unexpected inhibitory action of N-methyl-d,l-aspartate or luteinizing hormone release in adult ovariectomized rhesus monkeys: a role of the hypothalamic-adrenal axis. Endocrinology 127 2 (1990) 724-729
29. Sandberg M., Butcher S.P., and Hagberg H. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J. Neurochem. 47 1 (1986) 178-184
30. Schugens M.M., Egerter R., Daum I., Schepelmann K., Klockgether T., and Loschmann P.A. The NMDA antagonist memantine impairs classical eyeblink conditioning in humans. Neurosci. Lett. 224 1 (1997) 57-60
31. Schwenkreis P., Witscher K., Pleger B., Malin J.P., and Tegenthoff M. The NMDA antagonist memantine affects training induced motor cortex plasticity-a study using transcranial magnetic stimulation [ISRCTN65784760]. BMC Neurosci. 6 1 (2005) 35
32. Setchell K.D., Shackleton C.H., and Himsworth R.L. Studies on plasma corticosteroids in the rhesus monkey (Macaca mulatta). J. Endocrinol. 67 2 (1975) 241-250
33. Taborsky Jr. G.J., Ahrén B., and Havel P.J. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 47 7 (1998) 995-1005
34. Tokarev D., and Jezova D. Effect of central administration of the non-NMDA receptor antagonist DNQX on ACTH and corticosterone release before and during immobilization stress. Methods Find. Exp. Clin. Pharmacol. 19 5 (1997) 323-328
35. Veneman T., Mitrakou A., Mokan M., Cryer P., and Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 42 9 (1993) 1233-1237
36. Yousef K.A., Tepper P.G., Molina P.E., Abumrad N.N., and Lang C.H. Differential control of glucoregulatory hormone response and glucose metabolism by NMDA and kainate. Brain Res. 634 1 (1994) 131-140
37. Zelena D., Mergl Z., and Makara G.B. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons. Brain Res. 1031 2 (2005) 185-193
38. Zhou Y., Yuferov V.P., Spangler R., Maggos C.E., Ho A., and Kreek M.J. Effects of memantine alone and with acute 'binge' cocaine on hypothalamic-pituitary-adrenal activity in the rat. Eur. J. Pharmacol. 352 1 (1998) 65-71